Literature DB >> 32021666

An Open-Label Study of Low-Level Laser Therapy Followed by Autologous Fibroblast Transplantation for Healing Grade 3 Burn Wounds in Diabetic Patients.

Mohammad Ali Nilforoushzadeh1, Nooshafarin Kazemikhoo2,3, Soheila Mokmeli4, Sona Zare1,5, Mostafa Dahmardehei6, Reza Vaghar Doost6, Mahnoush Momeni6, Fereshteh Ansari7,8.   

Abstract

Introduction: Low-level laser therapy (LLLT) has been used as an effective therapeutic modality since the mid-1960s. Although there have been several clinical studies using LLLT in wound healing, especially diabetic, pressure and venous ulcers, there are few reports of using this technique in burn ulcers. Autologous fibroblast transplantation is a novel treatment for patients with burns or venous ulcers. In this study for the first time, we used LLLT along with autologous fibroblast skin transplantation to treat grade 3 burn ulcers in diabetic patients. This case series describes the successful management of grade 3 burn ulcers in 10 diabetic patients using autologous fibroblast transplantation along with LLLT.
Methods: After the approval of the Tehran University Ethics Committee (IR.TUMS.REC.1394.1683) and the Iran Registry of Clinical Trials (IRCT2016050226069N3), 10 diabetic patients with 10 grade 3 burn ulcers, who were a candidate for skin graft surgery, entered the study. Donor skin was biopsied using a 3 mm punch. Fibroblasts were extracted and cultured in vitro in the GMP Technique laboratory. The patients were treated using LLLT in 3-4 weeks during the time that fibroblast cultures became ready to use. Laser irradiation was done using red light, 650 nm, 150 mW, 1 J/cm2 for the bed of the ulcer and infra-red light 808 nm, 200 mW, 6 J/cm2 for the margins every other day for 10 sessions.
Results: The mean wound size before treatment was 16.28 cm2 . All patients' burn wounds healed completely after 10-12 weeks.
Conclusion: We conclude that this method can be used as an effective method for treating large wounds, especially in complicated patients including the diabetics.
Copyright © 2019 J Lasers Med Sci.

Entities:  

Keywords:  Autologous fibroblast transplantation; Burn wound; Low-level laser therapy

Year:  2019        PMID: 32021666      PMCID: PMC6983871          DOI: 10.15171/jlms.2019.S2

Source DB:  PubMed          Journal:  J Lasers Med Sci        ISSN: 2008-9783


  37 in total

Review 1.  Burn wound healing and skin substitutes.

Authors:  P Shakespeare
Journal:  Burns       Date:  2001-08       Impact factor: 2.744

2.  Skin replacement with a collagen based dermal substitute, autologous keratinocytes and fibroblasts in burn trauma.

Authors:  D Wisser; J Steffes
Journal:  Burns       Date:  2003-06       Impact factor: 2.744

Review 3.  Other uses of homologous skin grafts and skin bank bioproducts.

Authors:  Michele Fimiani; Elisa Pianigiani; Francesca Cherubini Di Simplicio; Paolo Sbano; Aldo Cuccia; Gerarda Pompella; Giovambattista De Aloe; Felice Petraglia
Journal:  Clin Dermatol       Date:  2005 Jul-Aug       Impact factor: 3.541

Review 4.  Cell therapy of burns.

Authors:  T Leclerc; C Thepenier; P Jault; E Bey; J Peltzer; M Trouillas; P Duhamel; L Bargues; M Prat; M Bonderriter; J-J Lataillade
Journal:  Cell Prolif       Date:  2011-04       Impact factor: 6.831

5.  Effect of low-level laser therapy on the healing process of donor site in patients with grade 3 burn ulcer after skin graft surgery (a randomized clinical trial).

Authors:  Reza Vaghardoost; Mahnoush Momeni; Nooshafarin Kazemikhoo; Soheila Mokmeli; Mostafa Dahmardehei; Fereshteh Ansari; Mohammad Ali Nilforoushzadeh; Parisa Sabr Joo; Sara Mey Abadi; Soheila Naderi Gharagheshlagh; Saeed Sassani
Journal:  Lasers Med Sci       Date:  2018-01-24       Impact factor: 3.161

6.  Comparison of the low level laser therapy effects on cultured human gingival fibroblasts proliferation using different irradiance and same fluence.

Authors:  L Almeida-Lopes; J Rigau; R A Zângaro; J Guidugli-Neto; M M Jaeger
Journal:  Lasers Surg Med       Date:  2001       Impact factor: 4.025

7.  Low-power laser and healing of burns: a preliminary assay.

Authors:  D C Cambier; G G Vanderstraeten; M J Mussen; J T van der Spank
Journal:  Plast Reconstr Surg       Date:  1996-03       Impact factor: 4.730

8.  Classification of diabetic foot wounds.

Authors:  L A Lavery; D G Armstrong; L B Harkless
Journal:  J Foot Ankle Surg       Date:  1996 Nov-Dec       Impact factor: 1.286

9.  Successful use of a physiologically acceptable artificial skin in the treatment of extensive burn injury.

Authors:  J F Burke; I V Yannas; W C Quinby; C C Bondoc; W K Jung
Journal:  Ann Surg       Date:  1981-10       Impact factor: 12.969

10.  Long-term outcome and disability of diabetic patients hospitalized for diabetic foot ulcers: a 6.5-year follow-up study.

Authors:  Edouard Ghanassia; Laetitia Villon; Jean-François Thuan Dit Dieudonné; Catherine Boegner; Antoine Avignon; Ariane Sultan
Journal:  Diabetes Care       Date:  2008-04-04       Impact factor: 19.112

View more
  4 in total

1.  Effects of intravenous and transdermal photobiomodulation on the postoperative complications of coronary artery bypass grafting surgery: a randomized, controlled clinical trial.

Authors:  Nooshafarin Kazemikhoo; Majid Kyavar; Zahra Razzaghi; Fereshteh Ansari; Majid Maleki; Alireza Alizadeh Ghavidel; Maziar Gholampour; Mohammad Hassan Ghaffarinejad
Journal:  Lasers Med Sci       Date:  2021-01-04       Impact factor: 3.161

2.  Low-level laser therapy is effective in controlling postoperative pain in lower third molar extractions: a systematic review and meta-analysis.

Authors:  Daiane Domingos de Barros; Josefa Simere Dos Santos Barros Catão; Alieny Cristina Duarte Ferreira; Thamyres Maria Silva Simões; Renata de Albuquerque Cavalcanti Almeida; Maria Helena Chaves de Vasconcelos Catão
Journal:  Lasers Med Sci       Date:  2022-01-11       Impact factor: 3.161

3.  Biostimulative effect of laser on growth of mesenchymal stem/stromal cells in vitro.

Authors:  Natalia Siedlecka; Kaja Mecinska-Jundzill; Ewelina Fierek; Zuzanna Fekner; Arkadiusz Jundzill; Marta Rasmus; Tomasz Kloskowski; Kamil Szeliski; Wieslaw Bienkowski; Rafal Czajkowski; Tomasz Drewa; Marta Pokrywczynska
Journal:  Postepy Dermatol Alergol       Date:  2020-11-07       Impact factor: 1.837

4.  MicroRNA-133b Inhibition Restores EGFR Expression and Accelerates Diabetes-Impaired Wound Healing.

Authors:  Haobo Zhong; Jin Qian; Zhihong Xiao; Yan Chen; Xiangchun He; Chunhan Sun; Zhiming Zhao
Journal:  Oxid Med Cell Longev       Date:  2021-11-27       Impact factor: 6.543

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.